These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Troponin I phosphorylation plays an important role in the relaxant effect of beta-adrenergic stimulation in mouse hearts. Peña JR, Wolska BM. Cardiovasc Res; 2004 Mar 01; 61(4):756-63. PubMed ID: 14985072 [Abstract] [Full Text] [Related]
3. Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. Layland J, Cave AC, Warren C, Grieve DJ, Sparks E, Kentish JC, Solaro RJ, Shah AM. FASEB J; 2005 Jul 01; 19(9):1137-9. PubMed ID: 15855227 [Abstract] [Full Text] [Related]
4. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Takimoto E, Soergel DG, Janssen PM, Stull LB, Kass DA, Murphy AM. Circ Res; 2004 Mar 05; 94(4):496-504. PubMed ID: 14726477 [Abstract] [Full Text] [Related]
5. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cazorla O, Szilagyi S, Vignier N, Salazar G, Krämer E, Vassort G, Carrier L, Lacampagne A. Cardiovasc Res; 2006 Feb 01; 69(2):370-80. PubMed ID: 16380103 [Abstract] [Full Text] [Related]
6. Enhanced N-terminal degradation of troponin I blunts cardiac function responsiveness to isoproterenol in 4-week tail-suspended rats. Zhang L, Song Z, Chang H, Wang YY, Yu ZB. Mol Med Rep; 2013 Jan 01; 7(1):271-9. PubMed ID: 23042367 [Abstract] [Full Text] [Related]
7. PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144. Wang H, Grant JE, Doede CM, Sadayappan S, Robbins J, Walker JW. J Mol Cell Cardiol; 2006 Nov 01; 41(5):823-33. PubMed ID: 17010989 [Abstract] [Full Text] [Related]
8. N-terminal phosphorylation of cardiac troponin-I reduces length-dependent calcium sensitivity of contraction in cardiac muscle. Rao VS, Korte FS, Razumova MV, Feest ER, Hsu H, Irving TC, Regnier M, Martyn DA. J Physiol; 2013 Jan 15; 591(2):475-90. PubMed ID: 23129792 [Abstract] [Full Text] [Related]
9. Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation. Wolska BM, Arteaga GM, Peña JR, Nowak G, Phillips RM, Sahai S, de Tombe PP, Martin AF, Kranias EG, Solaro RJ. Circ Res; 2002 May 03; 90(8):882-8. PubMed ID: 11988489 [Abstract] [Full Text] [Related]
10. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation. Gramolini AO, Trivieri MG, Oudit GY, Kislinger T, Li W, Patel MM, Emili A, Kranias EG, Backx PH, Maclennan DH. Proc Natl Acad Sci U S A; 2006 Feb 14; 103(7):2446-51. PubMed ID: 16461894 [Abstract] [Full Text] [Related]
11. Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Pi Y, Kemnitz KR, Zhang D, Kranias EG, Walker JW. Circ Res; 2002 Apr 05; 90(6):649-56. PubMed ID: 11934831 [Abstract] [Full Text] [Related]
12. Thyroid hormone inhibits slow skeletal TnI expression in cardiac TnI-null myocardial cells. Riedel B, Jia Y, Du J, Akerman S, Huang X. Tissue Cell; 2005 Feb 05; 37(1):47-51. PubMed ID: 15695175 [Abstract] [Full Text] [Related]
13. Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility. Zhao W, Uehara Y, Chu G, Song Q, Qian J, Young K, Kranias EG. J Mol Cell Cardiol; 2004 Aug 05; 37(2):607-12. PubMed ID: 15276030 [Abstract] [Full Text] [Related]
14. Regulation of cardiac contractile function by troponin I phosphorylation. Layland J, Solaro RJ, Shah AM. Cardiovasc Res; 2005 Apr 01; 66(1):12-21. PubMed ID: 15769444 [Abstract] [Full Text] [Related]
15. Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically. Layland J, Grieve DJ, Cave AC, Sparks E, Solaro RJ, Shah AM. J Physiol; 2004 May 01; 556(Pt 3):835-47. PubMed ID: 14966306 [Abstract] [Full Text] [Related]
16. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations. Coutu P, Bennett CN, Favre EG, Day SM, Metzger JM. Circ Res; 2004 May 14; 94(9):1235-41. PubMed ID: 15059934 [Abstract] [Full Text] [Related]
17. Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation. Scruggs SB, Walker LA, Lyu T, Geenen DL, Solaro RJ, Buttrick PM, Goldspink PH. J Mol Cell Cardiol; 2006 Apr 14; 40(4):465-73. PubMed ID: 16445938 [Abstract] [Full Text] [Related]
18. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection. Yu QJ, Si R, Zhou N, Zhang HF, Guo WY, Wang HC, Gao F. Apoptosis; 2008 Feb 14; 13(2):305-17. PubMed ID: 18165901 [Abstract] [Full Text] [Related]
19. Myofilament incorporation and contractile function after gene transfer of cardiac troponin I Ser43/45Ala. Lang SE, Robinson DA, Wu HC, Herron TJ, Wahr PA, Westfall MV. Arch Biochem Biophys; 2013 Jul 01; 535(1):49-55. PubMed ID: 23318976 [Abstract] [Full Text] [Related]
20. Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation. Li L, Desantiago J, Chu G, Kranias EG, Bers DM. Am J Physiol Heart Circ Physiol; 2000 Mar 01; 278(3):H769-79. PubMed ID: 10710345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]